Introduction

46
It is often necessary to genotype biological samples to select individuals from a large 47 population with a desired genetic variant. Genetic variants generated by mutagenesis or natural 48 variation can take the form of single nucleotide polymorphisms (SNPs) or insertions/deletions 49 (indels) . Sufficiently large indels can be distinguished using PCR followed by agarose or 50 polyacrylamide gel electrophoresis (PAGE), but differences of one or two base pairs can be 51 difficult to distinguish reliably even with PAGE, and SNP alleles are refractory to size-based 52 genotyping. Diagnostic tools for genotyping samples with SNPs or small indels include PCR-53 based cleaved amplified polymorphic sequences (CAPS) or derived CAPS markers (dCAPS) [1] . 54 A typical CAPS assay consists of a short amplicon centered on a restriction site present in only 55 one genotype. The CAPs assay identifies the genotype of the individual based on whether or not 56 the PCR product is cleaved by the differential restriction enzyme ( Fig 1A) . A dCAPS assay can 57 be used if there are no restriction sites differentially present in the wild-type and mutant genomic 58 sequences. The dCAPS assay introduces or disrupts a restriction enzyme motif near the mutation 59 by amplifying the target sequences using an oligonucleotide primer that includes one or more 60 mismatches relative to the template ( Fig 1B) . The mismatches are chosen so that following 61 amplification, a restriction site is introduced into either the wild-type or the mutant amplified 62 fragment, which can then be distinguished by restriction enzyme digestion followed by agarose 63 gel electrophoresis. 64
As CRISPR/Cas9-generated mutant alleles become more prevalent, there is a growing 65 need for a facile method for screening and genotyping indel alleles. Assays based on dCAPS 66 4 markers are ideal for this as they are simple, robust, inexpensive, and relatively high throughput. 67 However, designing productive primers for allele-specific dCAPS assays can be cumbersome. 68
Here, we present the development of a new web-based tool to design dCAPS primers for 69 indels that should be of general utility for analysis of CRISPR/Cas9-generated mutant alleles in 70 any species. We demonstrate the utility of this tool using CRISPR/Cas9 targeting of the AHK3 71 locus in Arabidopsis thaliana. AHK2, AHK3, and AHK4 are the three receptors present in 72
Arabidopsis that are involved in the perception of cytokinin, a plant hormone regulating a 73 diverse set of biological functions in plants [2] . Previous studies have identified null alleles of 74 ahk2 and ahk4, but the previously identified ahk3-3 allele is hypomorphic rather than a null 75 allele, as residual full-length AHK3 transcript was found to be present in seedlings harboring the 76 strongest ahk3 allele [3] . Primers generated by the indCAPS tool were successful at identifying 77 editing events at the AHK3 locus, and viable triple null mutant lines for the cytokinin histidine 78 kinase receptors were identified. The indCAPS tool has the potential to be an important resource 79 for investigators seeking to find new CRISPR alleles or design genotyping primers for known 80 alleles. 81
Materials and Methods
82
Software
83
The indCAPS package was written in Python (version 3.5.2) and is implemented as a web 84 application using the flask framework (0.12), the bleach package (1.5.0) for input scrubbing, and 85 the gunicorn WSGI HTTP server (19.7.1). It is provided through an OpenShift application 86 platform available from UNC-Chapel Hill. The website is available at 87 Oligonucleotide primers were designed to detect editing at the AHK3 locus using the 101 indCAPS tool. Amplification of the AHK3 locus was performed with primers AHK3.dC.F and 102 AHK3.dC.rc (Table 1) followed by digestion of the amplicon with Bsa BI. Digests were 103 analyzed using gel electrophoresis with a 3% agarose gel. Lines lacking any wild-type digestion 104 pattern were selected for analysis. Sanger sequencing was used to characterize editing events as 105 single base-pair indels and to confirm homozygosity. 106 While a web tool for the design of dCAPS primers has been described [7] , it was 111 designed primarily to detect SNP alleles. Primers generated with the tool for small indels often 112 will not actually amplify either the wild-type or mutant sequences by PCR, or in some cases will 113 not actually distinguish between the wild-type and mutant sequences. For example, an analysis 114 of potential dCAPS primers generated by the existing dCAPS program 115 (http://helix.wustl.edu/dcaps/dcaps.html) for indels in several genes in A. thaliana demonstrated 116 that as few as 15% of the suggested primers are capable of distinguishing the provided alleles 117 (AHK3, 50% capable; CENH3, 14%; AGO1, 17%; MED20, 13%; RB1, 15%). The reason 118 dCAPS Finder 2.0 falters on indel alleles is not clear as the source code is no longer available. 119
Results and Discussion
The non-functional primers either do not generate a diagnostic restriction site or likely would not 120 amplify the target DNA due to alignment gaps or extensive 3' mismatches between the primer 121 and one of the template sequences ( Fig 1C-F ). There are workaround methods in which the user 122 supplies two sequences in which the terminal base is the indel, rather than placing the indel in the 123 middle of the provided sequences. This approach will ignore any potential assays in which a 124 restriction motif may overlap the indel site, as the program has no information about bases on the 125 other side of the indel. 
A web-based tool for design of primers to detect indels: indCAPS 147 A new software package, indCAPS, was developed to facilitate the design of dCAPS 148 primers for indels. This software has also been adapted for the design of CAPS and dCAPS 149 oligonucleotide primers used in PCR amplification of target sequences in order to screen for 150 editing events following CRISPR/Cas9-mediated mutagenesis [9] . The tool is available at 151 http://indcaps.kieber.cloudapps.unc.edu. 152
The interface presents two dialog boxes to the user. The first box is for the generation of 153 dCAPS primers for known alleles. The second box is for the generation of dCAPS primers for 154 detecting unknown alleles. The first box requires the user to submit two sequences. No 155 assumptions are made about either sequence being a wild-type or mutant allele, so order does not 156 matter. Ideally, each sequence is centered on the mutation of interest. The two sequences do not 157 need to be the same length, but should have homology arms of at least 20 bases flanking the 158 mutation of interest. The user is also asked to submit a maximum number of mismatches in the 159 primer. The default value is 1 mismatch. Increasing the maximum mismatch value should result 160 in more enzymes being reported, but as with any hand-made dCAPS assay, this may result in 161 primers which are less likely to successfully amplify DNA. 162
Several advanced options are also available. Amplicon length can be specified. This 163 parameter dictates how far downstream the tool examines the sequence when looking for exact 164 matches for each restriction site. A restriction enzyme is rejected if there is a cleavage site in the 165 shared downstream region, which would complicate the analysis of the diagnostic cleavage at the 166 site of interest. Depending on the size of the submitted sequence, the amplicon length may be 167 longer than the sequence available to the program. In this case, the entire submitted sequence 168 9 downstream of the primer is considered. If the user intends to use a paired primer lying outside 169 the sequence supplied to the program, the user should check that either no exact restriction 170 digests are present in the region not shown to the program or any exact restriction sites will still 171 permit discrimination between diagnostic bands when analyzed with gel electrophoresis. Primers 172 can be chosen based on a strict primer length or by a target melting temperature. A target size 173 may be desired if the user wishes to ensure that a sufficiently large fragment will be cleaved. 174
This may be useful in GC rich areas where a primer designed to match a target melting 175 temperature would be short, resulting in small shifts in band sizes after cleavage and default assumption for this tool is that 3' mismatches will not amplify. If the user wishes to allow 185 certain 3' mismatches, the option is available. If enabled, 3' G/T mismatches are ignored. 186
The second box presented by the tool to the user permits screening for mutagenesis 187 events in a CRISPR-mediated mutagenesis experiment. The box requires the user to submit the 188 wild-type genomic sequence the user intends to target. The sequence should contain at least 189 twenty bases on each side of the cleavage site. The user should also include the 5' to 3' CRISPR 190 target site, not including the PAM. The CRISPR target sequence is not required to be in the same 191 10 orientation as the wild-type sequence. The tool assumes that the last base of the provided 192 sequence immediately precedes the PAM if aligned to the wild-type sequence and that cleavage 193 occurs at the -3 position. The mismatch max parameter behaves as it does in the first box. The 194 final major parameter is the acceptable loss threshold, which is the percent of editing events the 195 user is willing to miss with their screening. Lower values mean the user wants to detect more 196 editing events. Higher values mean the user is willing to accept missing certain editing events. 197
Missed editing events, in this context, are most likely to occur if an insertion event occurs 198 relative to an enzyme with degenerate bases in its recognition motif. The advanced options are 199 the same as for those in the first box. 200
An additional application is facilitated by the first box, the known-alleles tool. CRIPSR-201 mediated mutagenesis events create random mutations at the target locus. It may be desired in 202 some cases to generate an isogenic mutation in a novel biological context, such as a different 203 ecotype or genetic background. This is especially useful in cases where multiple mutant loci 204 must be maintained and introducing an isogenic mutation would prove easier than screening 205 multiple segregating loci as a result of a cross. The output of the known-alleles tool indicates 206 which of the two supplied sequences is cleaved by the restriction digest. If the user supplies the 207 wild-type sequence and the specific mutant sequence they wish to find and choose an assay 208 where the mutant sequence is cleaved, then a CAPS/dCAPS assay can be used to screen a pool of 209 CRISPR-generated mutants for a specific mutation. This could be feasibly accomplished by a 210 two-step process, where primers generated by the unknown allele indCAPS application are used 211 to screen for lines showing any evidence of CRISPR-mediated editing events, and then a second 212 primer set is used to screen for a specific mutation within that population. recognition-specificities). If a diagnostic site is detected, determined by an exact motif match in 228 only one sequence, a primer is generated. The primer disrupts any exact matches present in the 229 shared regions and is checked to ensure the mismatch number is less than the specified 230 maximum. 231 232 Two core assumptions are made when designing diagnostic assays: 1) designed primers 233 must be wholly contained in the shared region; and 2) putative restriction sites must have at least 234 one base pair of overlap with both the shared and unshared regions. A library of restriction 235 enzyme recognition sites (https://www.neb.com/tools-and-resources/selection-236 12 charts/alphabetized-list-of-recognition-specificities) (excluding nicking or double-cutting 237 enzymes) is compared to both shared regions and to a subsequence near the last shared base. An 238 enzyme is rejected if it cuts in the downstream shared region, and exact matches in the primer are 239 disrupted with mismatches during the primer design stage. Each set of sequences is analyzed 240 twice, once as supplied, and again using the reverse complement of each sequence. An enzyme 241 that is rejected because it cuts in the shared, downstream region of both sequences from one 242 direction may be suitable if the primer is aligned to the reverse complement of the two sequences. 243
For the purpose of CRISPR/Cas9 screening, a profile of possible editing events is used to 244 simulate editing events in the wild-type sequence. Currently, the default editing events are single 245 base pair insertion and deletion events. Future versions of the software will allow the user to 246 supply a custom profile of events. The user is required to provide the specific target sequence 247 used in CRISPR/Cas9 mutagenesis and the cut site is assumed to be at the -3 position of the 248 provided 20 bp target [9] . All possible sequence variants are created and compared to the wild-249 type sequence to identify the last shared base. The last shared base is taken to be the last base in 250 the wild-type sequence shared with all sequence variants. A simplifying assumption is made 251 when designing primers for unknown alleles: cleavage will occur in the wild-type sequence and 252 will be disrupted in mutant sequences. 253 254 255 Use of indCAPS to find mutants in cytokinin signaling 256 Cytokinins, a class of adenine-derived signaling molecules are involved in regulating a 257 diverse set of biological processes. Cytokinins are perceived by Arabidopsis Histidine Kinase 258 13 (AHK) proteins [16, 17] in the endoplasmic reticulum [18, 19] , which undergo 259 autophosphorylation on a His residue. This phosphate is ultimately transferred to either type-A or 260 type-B Response Regulator proteins (ARRs) via the Histidine Phosphotransfer (AHP) proteins 261 [20] [21] [22] . Type-B ARRs are transcription factors activated by phosphorylation [23] . Type-A 262
ARRs lack a DNA-binding domain, are cytokinin-inducible, and negatively regulate cytokinin 263 signaling [24, 25] . 264
The cytokinin AHK receptors are encoded by AHK2, AHK3, and AHK4/CRE1 in 265
Arabidopsis. Mutant lines with loss-of-function T-DNA insertion alleles of each gene have been 266 identified. The most severely affected triple mutant line, , ahk2-7 ahk3-3 cre1-12, harbors null 267 alleles for ahk2 and ahk4, but still contains residual full-length wild-type transcript for AHK3 [3] . 268
We sought to identify a CRISPR-induced null allele of ahk3 in an ahk2 ahk4 background by 269 introducing a frameshift mutation in AHK3. This would reveal the effect of complete disruption 270 of the AHK cytokinin receptors in Arabidopsis. 271
The indCAPS tool was tested by designing primers for a CRISPR mutagenesis 272 experiment targeting the AHK3 gene (Fig. 2) . A CRISPR/Cas9 target was designed to target the 273 first exon of AHK3 using the CRISPR-Plant resource [8] . The target site chosen is before the 274 Cyclases/Histidine kinases Associated Sensory Extracellular (CHASE) domain, the cytokinin 275 binding domain of the AHKs. The AHK3 targeting plasmid, pCH59, was stably transformed into 276 an ahk2-7 cre1-12 mutant line [16, 17, 26] , referred to as ahk2,4 hereafter. The pCH59 vector was 277 constructed by cloning a commercially synthesized gRNA fragment into a pCUT binary vector 278 system expressing plant codon optimized Cas9 [4] . T1 transformed seedlings were identified by 279 hygromycin selection and grown to maturity. The T2 progeny were screened for AHK3 editing 280 events using primers generated by indCAPS. Viable seedlings with homozygous, single base pair 281 14 insertions causing frameshift mutations disrupting the AHK3 coding region were identified. 282
These alleles, denoted ahk3-9 and ahk3-10, are single base pair insertions of A and C, 283 respectively. The frameshift produces an early stop 25 residues after the edit location. The 284 resulting predicted protein retains two transmembrane domains, but no functional CHASE 285 domain or cytosolic histidine kinase or receiver domains. These triple cre1-12 ahk2-7 ahk3 286 mutants were viable and resembled the cre1-12 ahk2-7 ahk3-3 [27] . These results demonstrate 287 that the complete disruption of all three AHK cytokinin receptors does not result in embryo 288 lethality. As these are the only CHASE-domain containing proteins in Arabidopsis, this suggests 289 that either cytokinin is not essential for early development, or that there are other as yet 290 unidentified cytokinin receptors. Offspring from two T2 plants heterozygous for editing events were selected and analyzed for 303 editing. (E) A. thaliana seedlings imaged at 2.5 weeks of growth. Shown are 304 15 ahk2, 4; . All plants at same scale. 306 307
Conclusions
308
The indCAPS package provides a useful tool for researchers using CRISPR-mediated 309 mutagenesis as it facilitates the screening of individuals in which editing of the target has 310 occurred. It also provides replacement for existing tools for the design of primers for dCAPS 311 analysis capable of distinguishing known indel alleles. We employed this tool to successfully 312 design diagnostic primers to identify CRISPR-induced ahk3 null alleles, the subsequent analysis 313 of which showed that the cytokinin AHK receptors are not essential for embryo development. 314
